MedPath

Motivational Interviewing Effects on Hypertensive Patients

Not Applicable
Conditions
Healthy lifestyle.
Maltreatment NOS
Registration Number
IRCT2014113017736N3
Lead Sponsor
Golestan University of Medical Science (Technology and Information Department)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
140
Inclusion Criteria

Inclusion criteria were as follows: 1) patients diagnosed with hypertension by a physician; 2) patients who received one antihypertensive medication at least; 3) patients who agreed to participate in the survey and more than 18 years old. Excluded criteria were as: 1) pregnant women and being pregnant during the study and 2) secondary hypertensive patients.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The laboratory and clinical indices (systolic blood pressure, the diastolic blood pressure, triglyceride level and total cholesterol, the symptoms of hypertension, and the complications of hypertension). Timepoint: Baseline (pre-test). Method of measurement: Laboratory and clinical sheet.;Blood pressure. Timepoint: Baseline (pre-test). Method of measurement: Blood test, when patient in sitting position, 5 minutes after sitting from the left arm.;Treatment Adherence. Timepoint: Baseline (pre-test). Method of measurement: Treatment Adherence Questionnaire of Patients with Hypertension (TAQPH).;Demographic status (included age, gender, marital status, educational level and diagnosis duration). Timepoint: Baseline (pre-test). Method of measurement: Demographic questionnaire.;Self-efficacy. Timepoint: Baseline (pre-test). Method of measurement: General Self-Efficacy Scale (GSES).;Quality of life. Timepoint: Baseline (pre-test). Method of measurement: Medical outcomes study 36- item short form (SF-36).
Secondary Outcome Measures
NameTimeMethod
Quality of life. Timepoint: Follow-up after 6 month. Method of measurement: Medical outcomes study 36- item short form (SF-36).;Self-efficacy. Timepoint: Follow-up after 6 month. Method of measurement: General Self-Efficacy Scale (GSES).;Treatment Adherence. Timepoint: Follow-up after 6 month. Method of measurement: Treatment Adherence Questionnaire of Patients with Hypertension (TAQPH).;The laboratory and clinical indices (systolic blood pressure, the diastolic blood pressure, triglyceride level and total cholesterol, the symptoms of hypertension, and the complications of hypertension(. Timepoint: Follow-up after 6 month. Method of measurement: Laboratory and clinical sheet.;Blood pressure. Timepoint: Follow-up after 6 month. Method of measurement: Blood test, when patient in sitting position, 5 minutes after sitting from the left arm.
© Copyright 2025. All Rights Reserved by MedPath